Public HealthAutoantibodies against type I IFNs in patients with life-threatening COVID-19September 24, 2020
Public HealthInborn errors of type I IFN immunity in patients with life-threatening COVID-19September 24, 2020
Public HealthUsing symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibilityAugust 24, 2020
Public HealthHelix Receives FDA Emergency Use Authorization for the Helix COVID-19 NGS Test, One of the First Sequencing-Based COVID-19 TestsAugust 10, 2020
Public HealthGenomics startup Helix receives $33 million in NIH funding to scale COVID-19 testingJuly 31, 2020
Public HealthHelix partners with San Diego County to make COVID-19 testing accessible for those who need it mostJuly 13, 2020
Helix PartnersSaliva is less sensitive than nasopharyngeal swabs for COVID-19 detection in the community settingMay 15, 2020
Public HealthSaliva-based COVID-19 testing is less sensitive than nasopharyngeal swabs in the community settingMay 15, 2020
Public HealthRevealing variants in SARS-CoV-2 interaction domain of ACE2 and loss of function intolerance through analysis of >200,000 exomesApril 18, 2020
